Related Experiment Videos
Summary
A child developed a lupus anticoagulant following measles, indicated by prolonged clotting times. Despite abnormal tests, surgery proceeded without complications, suggesting potential resilience to bleeding disorders.
Area of Science:
- Hematology
- Immunology
- Pediatrics
Background:
- Acquired lupus anticoagulant is a rare autoimmune condition affecting blood coagulation.
- Measles infection has been anecdotally linked to various autoimmune phenomena.
Observation:
- A 2-year-old boy presented with a lupus anticoagulant post-measles.
- Prolonged partial thromboplastin time and thromboplastin time were observed, with normal fibrinogen and thrombin time.
- Platelet count and function remained normal.
Findings:
- The patient's plasma demonstrated inhibitory activity against coagulation factors, confirmed by immunoglobulin fraction analysis.
- Mixing studies indicated immediate and persistent inhibition, characteristic of lupus anticoagulant.
- Despite prolonged clotting times, the patient underwent surgery without significant intraoperative bleeding or delayed wound healing.
Implications:
- This case highlights a rare post-infectious autoimmune complication of measles.
- It suggests that prolonged clotting times due to lupus anticoagulant may not always predict surgical bleeding risk in pediatric patients.
- Further research is needed to understand the mechanisms and clinical management of such cases.